Clinical Trials Browser

Phase 1/2 × Recruiting × Trifluridine × Clear all

NCT06873763 2025-07-11

Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal Cancer

Phase 1/2 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06202001 2024-04-02

Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients

Phase 1/2 Recruiting

Gastrointestinal

Colorectal Neoplasms